About the Authors
HENRI B. MEIER
Henri B. Meier is a co-founder of HBM BioVentures AG, HBM Partners AG, BioMedInvest AG, and BioMedCredit AG, which are among the global leaders in biotech venture capital firms. For the past 12 years, since his retirement from Roche, he has been very active in helping and advising young entrepreneurs start new companies and foundations.
From 1986 to 2000, Dr. Meier was Chief Financial Officer (CFO) and member of Roche Group's Executive Committee, and, from 1994 to 2004, he was a member of Roche's Board of Directors. At Roche, Henri Meier was responsible for treasury, accounting/controlling, corporate planning, strategic acquisitions/divestitures, and investments. He managed the purchase and sale of approximately CHF 15 billion of Roche's operating businesses and was able to tap international capital markets at exceptionally low financing costs. Among his most notable acquisitions were Genentech, Syntex, and Boehringer Mannheim, the latter of which made Roche the world leader in diagnostics. Henri Meier is known as the architect of Roche's modern financial structure and international accounting system. He has been honored as Switzerland's Top CFO and was a recipient of the European CFO Excellence Award. In addition to these accomplishments, Henri Meier was the co-initiator of the first Swiss venture ...
Get Swiss Finance: Capital Markets, Banking, and the Swiss Value Chain now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
